Canopy Growth Q2 EPS Estimate Lifted by Atb Cap Markets

Canopy Growth Corporation (NASDAQ:CGCFree Report) – Analysts at Atb Cap Markets boosted their Q2 2026 earnings per share estimates for Canopy Growth in a research report issued on Sunday, August 10th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings of ($0.15) per share for the quarter, up from their previous forecast of ($0.22). The consensus estimate for Canopy Growth’s current full-year earnings is ($2.81) per share. Atb Cap Markets also issued estimates for Canopy Growth’s Q3 2026 earnings at ($0.13) EPS, Q4 2026 earnings at ($0.12) EPS, FY2026 earnings at ($0.56) EPS, FY2027 earnings at ($0.36) EPS, FY2028 earnings at ($0.13) EPS, FY2029 earnings at ($0.08) EPS and FY2030 earnings at ($0.05) EPS.

Canopy Growth (NASDAQ:CGCGet Free Report) last issued its earnings results on Friday, August 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.01. Canopy Growth had a negative return on equity of 89.93% and a negative net margin of 155.76%. The firm had revenue of $52.98 million for the quarter, compared to analysts’ expectations of $64.98 million.

Separately, Piper Sandler reissued an “underweight” rating on shares of Canopy Growth in a research note on Friday, May 30th.

Get Our Latest Stock Analysis on CGC

Canopy Growth Trading Up 5.8%

Shares of NASDAQ CGC opened at $1.64 on Wednesday. The business’s 50 day moving average is $1.25 and its two-hundred day moving average is $1.36. The company has a debt-to-equity ratio of 0.59, a current ratio of 3.07 and a quick ratio of 2.10. Canopy Growth has a 1-year low of $0.77 and a 1-year high of $7.21. The stock has a market capitalization of $336.45 million, a P/E ratio of -0.54 and a beta of 0.67.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP bought a new position in shares of Canopy Growth during the fourth quarter valued at approximately $41,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of Canopy Growth by 81.3% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 32,336 shares of the company’s stock valued at $41,000 after buying an additional 14,498 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Canopy Growth by 56.5% during the first quarter. Mackenzie Financial Corp now owns 50,413 shares of the company’s stock valued at $47,000 after buying an additional 18,202 shares during the last quarter. Two Sigma Securities LLC grew its stake in shares of Canopy Growth by 150.1% during the fourth quarter. Two Sigma Securities LLC now owns 26,517 shares of the company’s stock valued at $73,000 after buying an additional 15,916 shares during the last quarter. Finally, Bayesian Capital Management LP bought a new position in shares of Canopy Growth during the fourth quarter valued at approximately $75,000. Institutional investors own 3.33% of the company’s stock.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

See Also

Earnings History and Estimates for Canopy Growth (NASDAQ:CGC)

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.